OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Viral Emerging Diseases: Challenges in Developing Vaccination Strategies
Maria Trovato, Rossella Sartorius, Luciana D’Apice, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 119
Maria Trovato, Rossella Sartorius, Luciana D’Apice, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 119
Showing 1-25 of 119 citing articles:
Pathogenicity and virulence of Marburg virus
Mehedy Hasan Abir, Tanjilur Rahman, Ayan Das, et al.
Virulence (2022) Vol. 13, Iss. 1, pp. 609-633
Open Access | Times Cited: 89
Mehedy Hasan Abir, Tanjilur Rahman, Ayan Das, et al.
Virulence (2022) Vol. 13, Iss. 1, pp. 609-633
Open Access | Times Cited: 89
Laboratory diagnosis of CNS infections in children due to emerging and re-emerging neurotropic viruses
Baoming Liu, Sarah B. Mulkey, Joseph M. Campos, et al.
Pediatric Research (2023) Vol. 95, Iss. 2, pp. 543-550
Closed Access | Times Cited: 76
Baoming Liu, Sarah B. Mulkey, Joseph M. Campos, et al.
Pediatric Research (2023) Vol. 95, Iss. 2, pp. 543-550
Closed Access | Times Cited: 76
Safety and effectiveness of SARS‐CoV‐2 vaccines: A systematic review and meta‐analysis
Yunzhi Ling, Jiaying Zhong, Jiaru Luo
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6486-6495
Open Access | Times Cited: 73
Yunzhi Ling, Jiaying Zhong, Jiaru Luo
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6486-6495
Open Access | Times Cited: 73
Application of microneedle patches for drug delivery; doorstep to novel therapies
Fateme Nazary Abrbekoh, Leila Salimi, Sepideh Saghati, et al.
Journal of Tissue Engineering (2022) Vol. 13
Open Access | Times Cited: 47
Fateme Nazary Abrbekoh, Leila Salimi, Sepideh Saghati, et al.
Journal of Tissue Engineering (2022) Vol. 13
Open Access | Times Cited: 47
Fighting the SARS-CoV-2 pandemic requires a global approach to understanding the heterogeneity of vaccine responses
Jeffrey Tomalka, Mehul S. Suthar, Steven G. Deeks, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 360-370
Open Access | Times Cited: 38
Jeffrey Tomalka, Mehul S. Suthar, Steven G. Deeks, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 360-370
Open Access | Times Cited: 38
COVID-19 Vaccines: Current and Future Perspectives
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 608-608
Open Access | Times Cited: 37
Luca Soraci, Fabrizia Lattanzio, Giulia Soraci, et al.
Vaccines (2022) Vol. 10, Iss. 4, pp. 608-608
Open Access | Times Cited: 37
COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons
Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah I. Tsiga-Ahmed, et al.
Vaccine (2023) Vol. 41, Iss. 15, pp. 2476-2484
Open Access | Times Cited: 24
Sahabi Kabir Sulaiman, Muhammad Sale Musa, Fatimah I. Tsiga-Ahmed, et al.
Vaccine (2023) Vol. 41, Iss. 15, pp. 2476-2484
Open Access | Times Cited: 24
Vaccine Target Discovery
Li Chuin Chong, Asif Manzoor Khan
Elsevier eBooks (2024)
Closed Access | Times Cited: 12
Li Chuin Chong, Asif Manzoor Khan
Elsevier eBooks (2024)
Closed Access | Times Cited: 12
Surveillance and prevalence of antimicrobial resistant bacteria from public settings within urban built environments: Challenges and opportunities for hygiene and infection control
Rory Cave, Jennifer Cole, Hermine V. Mkrtchyan
Environment International (2021) Vol. 157, pp. 106836-106836
Open Access | Times Cited: 53
Rory Cave, Jennifer Cole, Hermine V. Mkrtchyan
Environment International (2021) Vol. 157, pp. 106836-106836
Open Access | Times Cited: 53
Antiviral Cyanometabolites—A Review
Hanna Mazur‐Marzec, Marta Cegłowska, Robert Konkel, et al.
Biomolecules (2021) Vol. 11, Iss. 3, pp. 474-474
Open Access | Times Cited: 50
Hanna Mazur‐Marzec, Marta Cegłowska, Robert Konkel, et al.
Biomolecules (2021) Vol. 11, Iss. 3, pp. 474-474
Open Access | Times Cited: 50
Viral proteases as therapeutic targets
Taťána Majerová, Jan Konvalinka
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101159-101159
Open Access | Times Cited: 31
Taťána Majerová, Jan Konvalinka
Molecular Aspects of Medicine (2022) Vol. 88, pp. 101159-101159
Open Access | Times Cited: 31
Swine coronaviruses (SCoVs) and their emerging threats to swine population, inter-species transmission, exploring the susceptibility of pigs for SARS-CoV-2 and zoonotic concerns
Jigarji Chaturji Thakor, M. Dinesh, Rajendran Manikandan, et al.
Veterinary Quarterly (2022) Vol. 42, Iss. 1, pp. 125-147
Open Access | Times Cited: 27
Jigarji Chaturji Thakor, M. Dinesh, Rajendran Manikandan, et al.
Veterinary Quarterly (2022) Vol. 42, Iss. 1, pp. 125-147
Open Access | Times Cited: 27
First Genomic Evidence of a Henipa-like Virus in Brazil
Leonardo Henrique Almeida Hernández, Thito Yan Bezerra da Paz, Sandro Patroca da Silva, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 27
Leonardo Henrique Almeida Hernández, Thito Yan Bezerra da Paz, Sandro Patroca da Silva, et al.
Viruses (2022) Vol. 14, Iss. 10, pp. 2167-2167
Open Access | Times Cited: 27
Insight into non-nucleoside triazole-based systems as viral polymerases inhibitors
Roberta Bivacqua, Marilia Barreca, Virginia Spanò, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115136-115136
Open Access | Times Cited: 19
Roberta Bivacqua, Marilia Barreca, Virginia Spanò, et al.
European Journal of Medicinal Chemistry (2023) Vol. 249, pp. 115136-115136
Open Access | Times Cited: 19
The (Re-)Emergence and Spread of Viral Zoonotic Disease: A Perfect Storm of Human Ingenuity and Stupidity
Veronna Marie, Michelle Gordon
Viruses (2023) Vol. 15, Iss. 8, pp. 1638-1638
Open Access | Times Cited: 16
Veronna Marie, Michelle Gordon
Viruses (2023) Vol. 15, Iss. 8, pp. 1638-1638
Open Access | Times Cited: 16
Characterization and optimization of exopolysaccharide extracted from a newly isolated halotolerant cyanobacterium, Acaryochloris Al-Azhar MNE ON864448.1 with antiviral activity
Mabroka H. Saad, Nagwa M. Sidkey, Esmail M. El‐Fakharany
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Mabroka H. Saad, Nagwa M. Sidkey, Esmail M. El‐Fakharany
Microbial Cell Factories (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Editorial: Emerging and re-emerging viral infections: epidemiology, pathogenesis and new methods for control and prevention
Jawhar Gharbi, Giovanni Rezza, Manel Ben M’hadheb-Gharbi
Frontiers in Public Health (2025) Vol. 12
Open Access
Jawhar Gharbi, Giovanni Rezza, Manel Ben M’hadheb-Gharbi
Frontiers in Public Health (2025) Vol. 12
Open Access
Simultaneous detection of dengue virus serotypes in a dual-serotype-detection nucleic acid based lateral flow assay
Biswadeep Das, Sagnika Samal, Hamida Hamdi, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 111, Iss. 3, pp. 116679-116679
Closed Access
Biswadeep Das, Sagnika Samal, Hamida Hamdi, et al.
Diagnostic Microbiology and Infectious Disease (2025) Vol. 111, Iss. 3, pp. 116679-116679
Closed Access
Utilizing Vet-Informatics for Developing Reverse Genetics-Based Vaccine Platforms Against RNA Viruses Affecting Poultry and Livestock
Amreena Hassan, Irfan Gul, Naveed Anjum Chikan, et al.
(2025), pp. 415-438
Closed Access
Amreena Hassan, Irfan Gul, Naveed Anjum Chikan, et al.
(2025), pp. 415-438
Closed Access
Evolving Landscape of Emerging Virus Diagnosis: Challenges and Innovations
Anoop Kumar, Supriya Saini, Anupkumar R. Anvikar, et al.
Molecular Biotechnology (2025)
Closed Access
Anoop Kumar, Supriya Saini, Anupkumar R. Anvikar, et al.
Molecular Biotechnology (2025)
Closed Access
mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
Recent advances in immunotherapies against infectious diseases
Dharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, et al.
Immunotherapy Advances (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 48
Dharanidharan Ramamurthy, Trishana Nundalall, Sanele Cingo, et al.
Immunotherapy Advances (2020) Vol. 1, Iss. 1
Open Access | Times Cited: 48
Predictive Markers of Immunogenicity and Efficacy for Human Vaccines
Matthieu Van Tilbeurgh, Katia Lemdani, Anne‐Sophie Beignon, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 579-579
Open Access | Times Cited: 38
Matthieu Van Tilbeurgh, Katia Lemdani, Anne‐Sophie Beignon, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 579-579
Open Access | Times Cited: 38
Nanostructures for prevention, diagnosis, and treatment of viral respiratory infections: from influenza virus to SARS-CoV-2 variants
Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Esmaeel Sharifi, Satar Yousefiasl, Maria Trovato, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 13
Zebrafish as a model organism for virus disease research: Current status and future directions
Fajar Sofyantoro, Dwi Sendi Priyono, Nur Indah Septriani, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33865-e33865
Open Access | Times Cited: 4
Fajar Sofyantoro, Dwi Sendi Priyono, Nur Indah Septriani, et al.
Heliyon (2024) Vol. 10, Iss. 13, pp. e33865-e33865
Open Access | Times Cited: 4
